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IN PRACTICE
Clinical practice guidelines (CPGs) assist 
policymakers, managers, clinicians and 
patients to make evidence-informed health-
care decisions.[1] Most CPGs have been devel-
oped by reputable internationally recog nised 
groups with established methods, and expe-
rienced multidisciplinary teams (method-
ologists and content experts).[2-5] They are 
generally based in higher-income countries 
and focus on their healthcare priorities and 
systems.[6]
As more low- and middle-income countries 
(LMICs) use CPGs to improve healthcare 
practices, policymakers, managers and clini-
cians can draw on existing CPGs. However, 
these may be of questionable relevance to local 
settings (nature of practice, resources available, 
etc.) and local health priorities (country-
specific priorities such as HIV or TB in Africa). 
Consequently, CPG groups in these countries 
may opt to develop de novo locally relevant 
CPGs, rather than considering how they could 
efficiently ‘localise’ existing CPGs.
Developing de novo guidelines is expensive 
and time-consuming and requires CPG 
knowledge, skills and expertise, which are 
limited in LMICs, including South Africa 
(SA).[7] The need for evidence-informed and 
cost-efficient healthcare is urgent, and CPGs 
produced for local needs in these countries 
may have compromised quality and credibility 
and fail to meet international reporting 
standards for CPGs.[8] We have previously 
examined critical components of good-quality 
CPGs,[9] the potential of dedicated projects 
such as South African Guidelines Excellence 
(SAGE) to better understand the development, 
implementation and use of CPGs in SA 
primary care settings,[10] and the construction 
and management of effective, efficient and 
outcome-focused CPG teams.[11] An alternative 
approach to CPG development is proposed that 
involves adopting, contextualising or adapting 
existing CPGs to suit local purposes. We 
outline four steps for determining the need 
for developing de novo CPGs, or identifying 
an alternative (Fig. 1).
Step 1. Establish the 
CPG condition, target 
patient group and end-
users
Identify the condition, and the characteristics 
of patients for whom guidance is needed and 
who will use the CPG.
Step 2. Identify existing 
CPGs
Search reputable guideline sources for 
relevant CPGs. Several guideline sites allow 
free access to full CPGs developed for a 
range of conditions. Useful CPG resources 
can be accessed at http://www.mrc.ac.za/
cochrane/SAGEResources.pdf
Step 3. Screen the CPGs 
and decide whether de 
novo development is 
necessary
Check whether the CPG was published 
within the past 5 years and is of good 
quality using standardised tools[12-13] such as 
AGREE II[14] or the iCAHE tool.[15]
(a)   If a CPG is outdated or of poor quality, 
an update is recommended using formal 
de novo methods.[1,16]
(b)   If a CPG is current and of good quality, it 
is justifiable to use it and decide whether 
to adopt, contextualise or adapt the 
recommendations.
Step 4. Consider 
whether to adopt, adapt 
or contextualise
Step 4.1 Adopt
Decide to adopt if the CPG has recom-
mendations that are relevant and applicable 
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Fig. 1. Steps in determining the need for CPG de novo development and other CPG approaches.
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to local needs and settings. CPG adoption is a method where CPGs 
produced elsewhere are used as is, and directly implemented into 
practice.[17] Countries with the same patient types, health systems 
and resources should be able to adopt and implement such CPG 
recommendations.
Step 4.2 Contextualise
Decide to contextualise if the CPG has recommendations relevant 
to local needs; however, consideration of local context issues is 
required prior to implementation. CPG contextualisation is a method 
where recommendations from CPGs produced elsewhere can be 
adopted; however, additional information is required to address local 
contexts. [17-18]
Current good-quality CPGs for many conditions, such as chronic 
pain, should be applicable to patients in most settings. The challenge 
is to contextualise (localise the evidence to fit local contexts),[19] e.g. 
high-quality CPGs for chronic pain commonly recommend that 
patients should participate in individualised exercise programmes 
to improve function,[18-20] which is relevant to chronic pain patients 
internationally. However, this may be difficult to implement in many 
SA communities, as trained exercise instructors, exercise equipment 
or safe exercise spaces may not be available. To implement this CPG 
recommendation, contextualisation is therefore required (find a 
secure community space, and use mats, towels, and kitchen items for 
weights), and regular group/community exercise programmes may 
be implemented as alternative strategies.
Step 4.3 Adapt
Decide to adapt if CPG recommendations are unachievable in local 
circumstances, and new evidence must be added to make them 
relevant to local conditions and therefore implementable. CPG 
adaptation is a method where recommendations are taken from CPGs 
produced elsewhere but amended to include local research evidence 
and expert group consensus.[15] In adapting, a process of layering the 
evidence underpinning recommendations from existing CPGs with 
additional local evidence is used. For example, if drug A, which is 
recommended in high-quality CPGs for patients with acute stroke, 
is not available in a country (not registered, too expensive, cannot be 
safely stored, etc.) and instead drug B is locally available, affordable, 
with locally tested evidence and with equivalent benefits to drug A, 
the CPG recommendation could be adapted to suggest that drug B 
could be used.
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